Weed Grower Canopy Tempts Investors With Infused Drinks
Investing.com | Jun 23, 2020 09:48AM ET
Despite setbacks in the last year, top cannabis firm Canopy Growth (NYSE:CGC) (TSX:WEED) is still something of a trail-blazer in this relatively new industry that is constantly evolving. And shareholders got a taste of just that on Monday, when the company held its annual investor day.
The Ontario-based grower outlined its plan to focus on its “2.0 products,” namely cannabis-based vapes and infused drinks, as a means of improving its financial footing and regaining the market share it has lost in the past year.
The push to roll out cannabis-infused drinks is part of a strategy of marketing to a client base that is not interested in smoking. Company executives have reportedly said the idea is to reach customers that are looking for replacements for alcohol.
It is all part of Canopy’s drive to reinvigorate investor interest and improve upon a string of poor earnings results, including its most recent fourth-quarter report that included a C$1.3-billion ($960 million) net loss.
Canopy also plans to, as CEO David Klein reportedly put it, “make a lot of noise in the US,” by increasing its activity in the American cannabidiol (CBD) market.
Canopy Growth shares gained just under 0.25% on the New York Stock Exchange yesterday, closing at US$17.37, but lost just over half a percentage point on the Toronto Stock Exchange, closing at C$23.465. So far this year, Canopy shares on the NYSE have lost 18%.
Charlotte’s Web Sinks After IPO Announcement/h2
Shares of US-based CBD producer Charlotte's Web Holdings (OTC:CWBHF) had been seesawing their way upward since last month, until the company announced last Tuesday it plans to raise C$67.5 million ($49.8 million) in a public offering in Canada. The funds would be destined for business development and general working capital.
The stock fell more than 14% by the close of that day in New York and continued to drop, posting another 3.79% loss on Monday, to finish at $4.43.
Charlotte's Web shares last month were buoyed by news it had secured a US patent for an improved variety of hemp. This is the company’s second patent for hemp genetics, reinforcing the its reputation as a leader in the CBD market.
In the last quarter, the company recorded $21.5 million in sales, far outpacing other CBD producers.
For Hexo, The Bad News Keeps Coming/h2
Hexo (NYSE:HEXO) (TSX:HEXO) shares continued to fall throughout last week, after the Ottawa-based marijuana grower said it would seek to raise C$34.5 million ($25.4 million) in a new equity offering.
Hexo shares fell 11% that day, and continued to fall throughout the rest of the week and into Monday, when they closed 2% lower at $0.738 in New York and down 3% to C$0.99 in Toronto.
Jefferies analyst Owen Bennett was quoted as saying the equity offering will dilute Hexo shares by about 5%.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.